Displaying results 1 - 2 of 2
Clear search
Nxera Pharma joins the World Orphan Drug Alliance
Tokyo, Japan and Cambridge, UK, 8 April 2024 – Nxera Pharma Co. Ltd, formerly known as Sosei Group or Sosei Heptares – announces it has joined the World Orphan Drug Alliance (WODA), a global alliance of commercial distributors dedicated to providing access to treatments for rare diseases and specialty medicines in complex markets around the world. The Alliance consists of 12 member companies and…
PharmEnable Therapeutics and Sosei Heptares expand drug discovery collaboration
The collaboration combines Sosei Heptares’ leading structure-based drug design platform with PharmEnable’s advanced artificial intelligence-enabled platform for designing high quality novel chemistry leads on a second neurological disease target.